Could investigational drug become first-in-class bronchiectasis therapy?
The small molecule treatment is currently being reviewed by the…
The small molecule treatment is currently being reviewed by the US Food and Drug Administration (FDA), under the Prescription Drug User Fee Act (PDUFA).